When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Shares of Bellus Health(NASDAQ: BLU)(TSX: BLU) were falling 69.2% at 2:40 p.m. EST on Monday following its announcement that a phase 2 trial of BLU-5937 as a treatment for refractory chronic cough has missed its mark.
The biotech company says millions of patients suffer from chronic cough despite existing treatments, including Merck's (NYSE: MRK) gefapixant, a P2X3 antagonist associated with a side effect of taste loss that's hindered its use.